A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
Open Access
- 29 April 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (17) , eabm3108
Abstract
Dysregulated Wnt/β-catenin signaling is implicated in the pathogenesis of many human cancers, including colorectal cancer (CRC), making it an attractive clinical target. With the aim of inhibiting oncogenic Wnt activity, we developed a high-throughput screening AlphaScreen assay to identify selective small-molecule inhibitors of the interaction between β-catenin and its coactivator BCL9. We identified a compound that consistently bound to β-catenin and specifically inhibited in vivo native β-catenin/BCL9 complex formation in CRC cell lines. This compound inhibited Wnt activity, down-regulated expression of the Wnt/β-catenin signature in gene expression studies, disrupted cholesterol homeostasis, and significantly reduced the proliferation of CRC cell lines and tumor growth in a xenograft mouse model of CRC. This study has therefore identified a specific small-molecule inhibitor of oncogenic Wnt signaling, which may have value as a probe for functional studies and has important implications for the development of novel therapies in patients with CRC.Keywords
This publication has 89 references indexed in Scilit:
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Drugging Wnt signalling in cancerThe EMBO Journal, 2012
- Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptorNature Communications, 2012
- An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acidNature Communications, 2012
- Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein–Protein InteractionJournal of Medicinal Chemistry, 2011
- Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia developmentLeukemia, 2011
- β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome–aggresome–autophagosome–lysosome pathwayLeukemia, 2011
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1αNature Chemical Biology, 2010
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009